Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like <b>Sonoma Pharma</b> Release: Company Announces Fiscal Third Quarter 2017 Financial Results And Conference Call January 25, 2017 Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation November 29, 2017 Cellectis Reports Results From Annual General Meeting Held On June 26, 2017 June 26, 2017
<b>Sonoma Pharma</b> Release: Company Announces Fiscal Third Quarter 2017 Financial Results And Conference Call January 25, 2017
Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation November 29, 2017
